S

SynAct Pharma AB
STO:SYNACT

Watchlist Manager
SynAct Pharma AB
STO:SYNACT
Watchlist
Price: 20.45 SEK -0.49% Market Closed
Market Cap: 1.1B SEK

Operating Margin
SynAct Pharma AB

0%
Current
0%
Average
-4.1%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
0%
=
Operating Profit
-114.6m
/
Revenue
0

Operating Margin Across Competitors

No Stocks Found

SynAct Pharma AB
Glance View

Market Cap
1.1B SEK
Industry
Biotechnology

SynAct Pharma AB engages in the development of pharmaceutical drugs for the treatment of inflammatory diseases. The company is headquartered in Lund, Skane. The company went IPO on 2016-07-11. The firm is located in Lund, Sweden. The company develops medicines for acute impairment in inflammatory diseases. The firm's drug candidate AP1189 is intended for the treatment of arthritis including psoriasis arthritis.

SYNACT Intrinsic Value
13.58 SEK
Overvaluation 34%
Intrinsic Value
Price
S
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
0%
=
Operating Profit
-114.6m
/
Revenue
0
What is the Operating Margin of SynAct Pharma AB?

Based on SynAct Pharma AB's most recent financial statements, the company has Operating Margin of 0%.

Back to Top